Señales en vivo de 688513.SS | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 abr 2024 @ 03:00):

Stats
Volumen de hoy	574 704
Volumen promedio	457 115
Capitalización de mercado	7.27B
EPS	CNY0.510 ( 2023-10-26 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	29.84
ATR14	CNY0.0730 (0.12%)

Volumen Correlación

Largo: 0.08 (neutral)

Corto: 0.41 (neutral)

Signal:(47.912) Neutral

Chengdu Easton Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Chengdu Easton Correlación - Moneda/Commodity

0.18
( neutral )

-0.39
( neutral )

0.00
( neutral )

0.06
( neutral )

-0.02
( neutral )

-0.32
( neutral )

Chengdu Easton Finanzas

Annual	2023
Ingresos:	CNY1.12B
Beneficio Bruto:	CNY893.36M (80.00 %)
EPS:	CNY1.880

FY	2023
Ingresos:	CNY1.12B
Beneficio Bruto:	CNY893.36M (80.00 %)
EPS:	CNY1.880

FY	2023
Ingresos:	CNY0
Beneficio Bruto:	CNY0 (0.00 %)
EPS:	CNY0

FY	2022
Ingresos:	CNY1.17B
Beneficio Bruto:	CNY974.51M (83.25 %)
EPS:	CNY2.05

Financial Reports:

No articles found.

Chengdu Easton

Chengdu Easton Biopharmaceuticals Co., Ltd. engages in the research, development, manufacture, and commercialization of pharmaceutical products. The company provides finished dosage forms in anesthetic/analgesics, cardiovascular, oncology, pediatrics, and other therapeutic fields. It also offers active pharmaceutical ingredients in oncology, cardiovascular, anesthetic/analgesics, anti-inflammatory, gastrointestinal, antiemetic, neurology/psychiatry , and urinary system therapeutic categories. The company was founded in 2009 and is based in Chengdu, China.